Sphingosine-1-phosphate	NN
is	VBZ
increased	VBN
in	IN
patients	NNS
with	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
and	CC
mediates	VBZ
epithelial	JJ
to	TO
mesenchymal	JJ
transition	NN
.	.

BACKGROUND	NN
:	:
Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
characterised	VBN
by	IN
the	DT
aberrant	JJ
epithelial	JJ
to	TO
mesenchymal	JJ
transition	NN
(	(
EMT	NN
)	)
and	CC
myofibroblast	NN
accumulation	NN
.	.

Sphingosine-1-phosphate	JJ
(	(
S1P	NN
)	)
and	CC
sphingosine	NN
kinase	NN
1	CD
(	(
SPHK1	NN
)	)
have	VBP
been	VBN
implicated	VBN
in	IN
lung	NN
myofibroblast	NN
transition	NN
,	,
but	CC
their	PRP$
role	NN
in	IN
EMT	NNP
and	CC
their	PRP$
expression	NN
in	IN
patients	NNS
with	IN
IPF	NN
is	VBZ
unknown	JJ
.	.

METHODS	NNS
AND	CC
RESULTS	NNS
:	:
S1P	NN
levels	NNS
were	VBD
measured	VBN
in	IN
serum	NN
(	(
n	NN
=	JJ
27	CD
)	)
and	CC
bronchoalveolar	JJ
lavage	NN
(	(
BAL	NN
;	:
n	NN
=	JJ
15	CD
)	)
from	IN
patients	NNS
with	IN
IPF	NN
and	CC
controls	NNS
(	(
n	NN
=	JJ
30	CD
for	IN
serum	NN
and	CC
n	NN
=	JJ
15	CD
for	IN
BAL	NN
studies	NNS
)	)
.	.

SPHK1	NN
expression	NN
was	VBD
measured	VBN
in	IN
lung	NN
tissue	NN
from	IN
patients	NNS
with	IN
IPF	NN
(	(
n	NN
=	JJ
12	CD
)	)
and	CC
controls	NNS
(	(
n	NN
=	JJ
15	CD
)	)
.	.

Alveolar	JJ
type	NN
II	CD
transformation	NN
into	IN
mesenchymal	JJ
cells	NNS
was	VBD
studied	VBN
in	IN
response	NN
to	TO
S1P	NN
(	(
10	CD
(	(
-9	CD
)	)
-10	CD
(	(
-5	CD
)	)
M	NN
)	)
.	.

The	DT
median	NN
(	(
IQR	NN
)	)
of	IN
S1P	NN
serum	NN
levels	NNS
was	VBD
increased	VBN
in	IN
patients	NNS
with	IN
IPF	NN
(	(
1.4	CD
(	(
0.4	CD
)	)
M	NN
)	)
versus	CC
controls	NNS
(	(
1	CD
(	(
0.26	CD
)	)
M	NN
;	:
p	NN
<	JJR
0.0001	CD
)	)
.	.

BAL	NN
S1P	NN
levels	NNS
were	VBD
increased	VBN
in	IN
patients	NNS
with	IN
IPF	NN
(	(
1.12	CD
(	(
0.53	CD
)	)
M	NN
)	)
versus	CC
controls	NNS
(	(
0.2	CD
(	(
0.5	CD
)	)
;	:
p	NN
<	JJR
0.0001	CD
)	)
and	CC
correlated	VBD
with	IN
diffusion	NN
capacity	NN
of	IN
the	DT
lung	NN
for	IN
carbon	NN
monoxide	NN
,	,
forced	VBD
expiratory	JJ
volume	NN
in	IN
1	CD
s	NNS
and	CC
forced	VBD
vital	JJ
capacity	NN
(	(
Spearman	NN
's	POS
r	NN
=	JJ
-0.87	CD
,	,
-0.72	CD
and	CC
-0.68	CD
,	,
respectively	RB
)	)
in	IN
patients	NNS
with	IN
IPF	NN
.	.

SPHK1	NN
was	VBD
upregulated	VBN
in	IN
lung	NN
tissue	NN
from	IN
patients	NNS
with	IN
IPF	NN
and	CC
correlated	VBD
with	IN
a-smooth-muscle-actin	NN
,	,
vimentin	NN
and	CC
collagen	NN
type	NN
I	CD
(	(
Spearman	NNP
's	POS
r	NN
=	JJ
0.82	CD
,	,
0.85	CD
and	CC
0.72	CD
,	,
respectively	RB
)	)
.	.

S1P	NN
induced	VBD
EMT	NNP
in	IN
alveolar	JJ
type	NN
II	CD
cells	NNS
by	IN
interacting	VBG
with	IN
S1P	NN
(	(
2	CD
)	)
and	CC
S1P	NN
(	(
3	CD
)	)
,	,
as	RB
well	RB
as	IN
by	IN
the	DT
activation	NN
of	IN
p-Smad3	NN
,	,
RhoA-GTP	NN
,	,
oxidative	JJ
stress	NN
and	CC
transforming-growth-factor-b1	NN
(	(
TGF-b1	NN
)	)
release	NN
.	.

Furthermore	RB
,	,
TGF-b1-induced	JJ
EMT	NN
was	VBD
partially	RB
conducted	VBN
by	IN
the	DT
S1P/SPHK1	NN
activation	NN
,	,
suggesting	VBG
crosstalk	NN
between	IN
TGF-b1	NN
and	CC
the	DT
S1P/SPHK1	NN
axis	NN
.	.

CONCLUSIONS	NNS
:	:
S1P	NN
is	VBZ
elevated	JJ
in	IN
patients	NNS
with	IN
IPF	NN
,	,
correlates	VBZ
with	IN
the	DT
lung	NN
function	NN
and	CC
mediates	VBZ
EMT	NNP
.	.

